IONIS PHARMACEUTICALS INC's ticker is and the CUSIP is 462222950. A total of 4 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $358,344 | +61.7% | 7,900 | +46.3% | 0.00% | 0.0% |
| Q2 2023 | $221,562 | +138.4% | 5,400 | +107.7% | 0.00% | – |
| Q1 2023 | $92,924 | -90.1% | 2,600 | -89.5% | 0.00% | -100.0% |
| Q4 2022 | $936,696 | +1070.9% | 24,800 | +1277.8% | 0.00% | – |
| Q3 2022 | $80,000 | -67.7% | 1,800 | -73.1% | 0.00% | – |
| Q2 2022 | $248,000 | +28.5% | 6,700 | +28.8% | 0.00% | – |
| Q1 2022 | $193,000 | -76.9% | 5,200 | -81.1% | 0.00% | -100.0% |
| Q4 2021 | $837,000 | -35.5% | 27,500 | -28.9% | 0.00% | 0.0% |
| Q3 2021 | $1,298,000 | -22.1% | 38,700 | -7.4% | 0.00% | -50.0% |
| Q2 2021 | $1,667,000 | -27.0% | 41,800 | -17.7% | 0.00% | -33.3% |
| Q1 2021 | $2,284,000 | +27.0% | 50,800 | +59.7% | 0.00% | 0.0% |
| Q4 2020 | $1,798,000 | +84.8% | 31,800 | +55.1% | 0.00% | 0.0% |
| Q3 2020 | $973,000 | +179.6% | 20,500 | +247.5% | 0.00% | +50.0% |
| Q2 2020 | $348,000 | -62.5% | 5,900 | -69.9% | 0.00% | -75.0% |
| Q1 2020 | $927,000 | -76.3% | 19,600 | -69.8% | 0.01% | -70.4% |
| Q4 2019 | $3,915,000 | +17.7% | 64,800 | +16.8% | 0.03% | 0.0% |
| Q3 2019 | $3,325,000 | -71.7% | 55,500 | -69.6% | 0.03% | -74.5% |
| Q2 2019 | $11,736,000 | -38.9% | 182,600 | -22.8% | 0.11% | -50.5% |
| Q1 2019 | $19,205,000 | +40.3% | 236,600 | -6.6% | 0.21% | +79.8% |
| Q4 2018 | $13,688,000 | +7.7% | 253,200 | +2.7% | 0.12% | +19.0% |
| Q3 2018 | $12,714,000 | +31.8% | 246,500 | +6.5% | 0.10% | +22.0% |
| Q2 2018 | $9,647,000 | +259.4% | 231,500 | +280.1% | 0.08% | +203.7% |
| Q1 2018 | $2,684,000 | -71.4% | 60,900 | -67.4% | 0.03% | -59.1% |
| Q4 2017 | $9,401,000 | -21.5% | 186,900 | -20.9% | 0.07% | -39.4% |
| Q3 2017 | $11,980,000 | +19.8% | 236,300 | +20.2% | 0.11% | +4.8% |
| Q2 2017 | $10,001,000 | +52.3% | 196,600 | +20.4% | 0.10% | +36.8% |
| Q1 2017 | $6,565,000 | -32.7% | 163,300 | -20.0% | 0.08% | -20.0% |
| Q4 2016 | $9,757,000 | +27.2% | 204,000 | -2.5% | 0.10% | +14.5% |
| Q3 2016 | $7,669,000 | +114.8% | 209,300 | +36.5% | 0.08% | +97.6% |
| Q2 2016 | $3,570,000 | +54.3% | 153,300 | +168.5% | 0.04% | +27.3% |
| Q1 2016 | $2,313,000 | -75.8% | 57,100 | -63.0% | 0.03% | -70.8% |
| Q4 2015 | $9,568,000 | – | 154,500 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Twin Tree Management, LP | 110,700 | $5,021,352 | 0.01% |
| GROUP ONE TRADING, L.P. | 7,900 | $358,344 | 0.00% |
| JANE STREET GROUP, LLC | 55,800 | $2,531,088 | 0.00% |
| SIMPLEX TRADING, LLC | 22,700 | $1,029 | 0.00% |
| JPMORGAN CHASE & CO | 30,000 | $1,360,800 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |